BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 38753242)

  • 1. Correction to: Correlation Between Plasma and Fecal Biomarkers and Patient‑Reported Outcomes in Patients with Crohn's Disease and Ulcerative Colitis.
    Motwani KK; Alizadeh M; Abutaleb A; Grossman J; Wellington J; Cross RK;
    Dig Dis Sci; 2024 Jun; 69(6):2164. PubMed ID: 38753242
    [No Abstract]   [Full Text] [Related]  

  • 2. Redo IPAA After a Failed Pouch In Patients With Crohn's Disease: Is It Worth Trying?
    Lavryk OA; Stocchi L; Shawki S; Aiello A; Church JM; Steele SR; Hull TL
    Dis Colon Rectum; 2020 Jun; 63(6):823-830. PubMed ID: 32384407
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neopterin concentration as an index of disease activity in Crohn's disease and ulcerative colitis.
    Husain N; Tokoro K; Popov JM; Naides SJ; Kwasny MJ; Buchman AL
    J Clin Gastroenterol; 2013 Mar; 47(3):246-51. PubMed ID: 23269308
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of plasma Short chain fatty acid levels as markers for Inflammatory bowel disease.
    Kiasat A; Rautiainen S; Prast-Nielsen S; Engstrand L; Schuppe-Koistinen I; Gustafsson UO; Löf Granström A
    Scand J Gastroenterol; 2023; 58(11):1246-1252. PubMed ID: 37272725
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of fecal granulocyte excretion in ulcerative colitis and Crohn's colitis.
    Saverymuttu SH; Hodgson HJ; Chadwick VS
    Dig Dis Sci; 1984 Nov; 29(11):1000-4. PubMed ID: 6489079
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fecal radioiodide excretion following intravenous injection of 131-I-albumin and 125-I-immunoglobulin G in chronic inflammatory bowel disease. An aid to topographic diagnosis.
    Jarnum S; Jensen KB
    Gastroenterology; 1975 Jun; 68(6):1433-44. PubMed ID: 1132626
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intestinal fatty acid binding protein is a disease biomarker in paediatric coeliac disease and Crohn's disease.
    Logan M; MacKinder M; Clark CM; Kountouri A; Jere M; Ijaz UZ; Hansen R; McGrogan P; Russell RK; Gerasimidis K
    BMC Gastroenterol; 2022 May; 22(1):260. PubMed ID: 35606704
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic determinants associated with early age of diagnosis of IBD.
    Connelly TM; Berg AS; Harris L; Brinton D; Deiling S; Koltun WA
    Dis Colon Rectum; 2015 Mar; 58(3):321-7. PubMed ID: 25664710
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PMN-elastase in assessment of patients with inflammatory bowel disease.
    Andus T; Gross V; Caesar I; Krumm D; Hosp J; Gerok W; Schölmerich J
    Dig Dis Sci; 1993 Sep; 38(9):1638-44. PubMed ID: 8359075
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Poor diagnostic value of colonic CD44v6 expression and serum concentrations of its soluble form in the differentiation of ulcerative colitis from Crohn's disease.
    Reinisch W; Heider KH; Oberhuber G; Dejaco C; Müllner M; Adolf GR; Gasché C
    Gut; 1998 Sep; 43(3):375-82. PubMed ID: 9863483
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Distinct patterns of naive, activated and memory T and B cells in blood of patients with ulcerative colitis or Crohn's disease.
    Rabe H; Malmquist M; Barkman C; Östman S; Gjertsson I; Saalman R; Wold AE
    Clin Exp Immunol; 2019 Jul; 197(1):111-129. PubMed ID: 30883691
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased nitric oxide production and inducible nitric oxide synthase activity in colonic mucosa of patients with active ulcerative colitis and Crohn's disease.
    Kimura H; Miura S; Shigematsu T; Ohkubo N; Tsuzuki Y; Kurose I; Higuchi H; Akiba Y; Hokari R; Hirokawa M; Serizawa H; Ishii H
    Dig Dis Sci; 1997 May; 42(5):1047-54. PubMed ID: 9149061
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Birth outcome in women with ulcerative colitis and Crohn's disease, and pharmacoepidemiological aspects of anti-inflammatory drug therapy.
    Nørgård BM
    Dan Med Bull; 2011 Dec; 58(12):B4360. PubMed ID: 22142578
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fecal lysozyme in assessment of disease activity in inflammatory bowel disease.
    van der Sluys Veer A; Brouwer J; Biemond I; Bohbouth GE; Verspaget HW; Lamers CB
    Dig Dis Sci; 1998 Mar; 43(3):590-5. PubMed ID: 9539656
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tissue IgG4-positive plasma cells in inflammatory bowel disease: a study of 88 treatment-naive biopsies of inflammatory bowel disease.
    Virk R; Shinagare S; Lauwers GY; Yajnik V; Stone JH; Deshpande V
    Mod Pathol; 2014 Mar; 27(3):454-9. PubMed ID: 23929268
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical features and oncological outcomes of intestinal cancers associated with ulcerative colitis and Crohn's disease.
    Noguchi T; Ishihara S; Uchino M; Ikeuchi H; Okabayashi K; Futami K; Tanaka S; Ohge H; Nagahara H; Watanabe K; Itabashi M; Okamoto K; Okita Y; Mizushima T; Mizuuchi Y; Yamada K; Shimada Y; Sato Y; Kimura H; Takahashi K; Hida K; Kinugasa Y; Okuda J; Daito K; Koyama F; Ueno H; Yamamoto T; Hanai T; Maemoto A; Oba K; Ajioka Y; Sugihara K;
    J Gastroenterol; 2023 Jan; 58(1):14-24. PubMed ID: 36182971
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Familial occurrence and inheritance studies in inflammatory bowel disease.
    Binder V; Orholm M
    Neth J Med; 1996 Feb; 48(2):53-6. PubMed ID: 8819799
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A SPECIAL MEETING REVIEW EDITION: Highlights in Inflammatory Bowel Disease From the 14th Congress of ECCO: A Review of Selected Presentations From the 14th Congress of the European Crohn's and Colitis Organisation (ECCO) • March 6-9, 2019 • Copenhagen, Denmark
    Gastroenterol Hepatol (N Y); 2019 May; 15(5 Suppl 2):1-24. PubMed ID: 31632213
    [No Abstract]   [Full Text] [Related]  

  • 19. Elevated ectodomain of type 23 collagen is a novel biomarker of the intestinal epithelium to monitor disease activity in ulcerative colitis and Crohn's disease.
    Manon-Jensen T; Sun S; Lindholm M; Domislović V; Giuffrida P; Brinar M; Mazza G; Pinzani M; Krznarić Z; Di Sabatino A; Karsdal MA; Mortensen JH
    United European Gastroenterol J; 2021 Mar; 9(2):268-278. PubMed ID: 33351719
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of serological markers to differentiate between ulcerative colitis and Crohn's disease: pANCA, ASCA and agglutinating antibodies to anaerobic coccoid rods.
    Linskens RK; Mallant-Hent RC; Groothuismink ZM; Bakker-Jonges LE; van de Merwe JP; Hooijkaas H; von Blomberg BM; Meuwissen SG
    Eur J Gastroenterol Hepatol; 2002 Sep; 14(9):1013-8. PubMed ID: 12352222
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.